Skip to search formSkip to main contentSkip to account menu

pirmenol

Known as: 2-Pyridinemethanol, alpha-(3-(2,6-dimethyl-1-piperidinyl)propyl)-alpha-phenyl-, monohydrochloride, cis-(+-)-, cis-alpha-(3-(2,6-dimethyl-1-piperidinyl)propyl)-alpha-phenyl-2-pyridinemethanol monohydrochloride 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

Anti-Arrhythmia AgentsPiperidines
Pirmenol:MCnc:Pt:Ser/Plas:Qn

Narrower (1)

pirmenol hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Inhibitory effects of class I antiarrhythmic agents on Na+ and Ca2+ currents of human iPS cell-derived cardiomyocytes
1992
1992
Selectivity of class I antiarrhythmic agents, disopyramide, pirmenol, and pentisomide for peripheral muscarinic M2 and M3 receptors.
The interactions of the class I antiarrhythmic agents, disopyramide, pirmenol, and pentisomide with peripheral muscarinic… 
1991
1991
Pirmenol: An antiarrhythmic drug with unique electrocardiographic features—a double‐blind placebo‐controlled comparison with quinidine
Previous reports have stated that pirmenol is a Class IA antiarrhythmic drug that prolongs the QT interval, but did not use… 
1988
1988
Antiarrhythmic plasma concentrations of pirmenol on canine ventricular arrhythmias.
Using two-stage coronary ligation-, digitalis- and adrenaline-induced canine ventricular arrhythmias, antiarrhythmic effects of… 
1986
1986
Electrophysiological and Cardiovascular Effects of Pirmenol, a New Class 1 Antiarrhythmic Drug
Summary: Pirmenol, a new antiarrhythmic agent, has been studied in the pithed rat and in the sinoatrial (SA) node, atrium… 
1985
1985
Antiarrhythmic efficacy of pirmenol in the treatment of premature ventricular complexes.
We assessed the antiarrhythmic effectiveness, therapeutic plasma concentrations and adverse effects of pirmenol in 16 patients… 
1983
1983
Disposition of Intravenous Pirmenol
Abstract: Twelve patients having frequent premature ventricular complexes (PVCs) averaging more than 60 per hour received a… 
Highly Cited
1982
Highly Cited
1982
Pirmenol, A New Antiarrhythmic Agent: Initial Study of Efficacy, Safety and Pharmacokinetics
Pirmenol (CI-845), a new antiarrhythmic drug, was studied for the first time in humans to establish a minimum effective i.v. dose… 
1982
1982
Pirmenol kinetics and effective oral dose
The oral form of pirmenol has not been administered to man. Pirmenol was given by mouth to eight patients with chronic, stable… 
1982
1982
Hemodynamic effects of the antiarrhythmic drug pirmenol
We examined the hemodynamic effects of pirmenol, a new antiarrhythmic drug, for the first time in man. Right and left heart… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)